Clinical trial Recruiting at 1 site Observational Ages 1 Year to 8

Preoperative blood inflammation markers to predict nausea after orchiopexy in children

Official title: Association of Preoperative Inflammatory Biomarkers With Postoperative Nausea and Vomiting in Children Undergoing Orchiopexy

Run by Diskapi Yildirim Beyazit Education and Research Hospital · NCT07148063 · Data updated 2026-11-12

This project will test whether preoperative blood inflammation markers can help predict which children aged 1–8 will have nausea and vomiting after orchiopexy.

More Postoperative Nausea and Vomiting trials

Quick facts

Study typeObservational
Ages1 Year to 8 Years
SexAll
Enrollment170 (estimated)
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
Government
Locations1 site (Altındağ, Ankara)
StatusRecruiting
StartedSeptember 8, 2025
Main results expectedMarch 13, 2026
Study endsMarch 27, 2026
Registry record updatedSeptember 9, 2025
Trial IDNCT07148063 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1–8 years with ASA physical status I–II who are scheduled for elective orchiopexy and whose parents/guardians can give informed consent.

Probably not a fit

Children outside the 1–8 year range, those with active infections, ASA III or higher, or a history of prior nausea/vomiting are excluded and unlikely to benefit from these findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will enroll children aged 1–8 undergoing elective orchiopexy and record preoperative inflammatory markers including NLR, PLR, SII, MLR, and SIRI. Blood counts will be measured before surgery and patients will be monitored for postoperative nausea and vomiting during the immediate recovery period. Researchers will analyze whether baseline marker levels correlate with PONV incidence while excluding children with active infection, prior nausea/vomiting history, or ASA III+ status. The goal is to see if routine laboratory measures can identify higher-risk children for targeted prophylaxis.

Why it matters

Potential benefit: If successful, clinicians could use routine preoperative blood counts to identify children at higher risk of PONV and offer targeted anti-nausea prevention.

How similar studies have gone: Previous adult and some pediatric studies have linked inflammatory markers like NLR and PLR to postoperative complications and PONV risk, but applying SII, MLR, and SIRI specifically to young orchiopexy patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 1 and 8 years
* Patients with ASA physical status I-II
* Patients scheduled for elective orchiopexy
* Obtained written informed consent from parents/guardians

Exclusion Criteria:

* Patients younger than 1 year or older than 8 years
* Patients with ASA physical status III or higher
* Presence of acute infection signs
* History of previous nausea or vomiting

Where it's running

  • Ankara Etlik City Hospital
    Altındağ, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.